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Background: Many Taiwanese women (43.8%) did not participate in regular cervical screening in 2011. An
alternative to cervical screening, self-sampling for human papillomavirus (HPV), has been available at no cost under
Taiwan’s National Health Insurance since 2010, but the extent and likelihood of HPV self-sampling were unknown.
Methods: A cross-sectional study was performed to explore determinants of women’s likelihood of HPV self-sampling.
Data were collected by questionnaire from a convenience sample of 500 women attending hospital gynecologic clinics
in central Taiwan from June to October 2012. Data were analyzed by descriptive statistics, chi-square test, and logistic
regression.
Results: Of 500 respondents, 297 (59.4%) had heard of HPV; of these 297 women, 69 (23%) had self-sampled for HPV.
Among the 297women who had heard of HPV, 234 (78.8%) considered cost a priority for HPV self-sampling. Likelihood
of HPV self-sampling was determined by previous Pap testing, high perceived risk of cervical cancer, willingness to
self-sample for HPV, high HPV knowledge, and cost as a priority consideration.
Conclusions: Outreach efforts to increase the acceptability of self-sampling for HPV testing rates should target women
who have had a Pap test, perceive themselves at high risk for cervical cancer, are willing to self-sample for HPV, have a
high level of HPV knowledge, and for whom the cost of self-sampling covered by health insurance is a priority.
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Cervical cancer is the second most common cancer in
women worldwide, with over 529,000 new cases and
275,000 deaths in 2010 [1]. Most women with cervical
cancer have never been or are not regularly screened [2].
However, cervical screening is crucial for early detection
of precancerous lesions. Cervical cancer screening has
traditionally been done by physicians using the Pap test,
which many women perceive as uncomfortable and
embarrassing [3-7]. A potential alternative to the Pap
test in Western countries has been vaginal self-sampling
for human papillomavirus (HPV) [5,8,9], the causative* Correspondence: tyaling@mail.cmu.edu.tw
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unless otherwise stated.agent for most cervical cancers [10]. HPV self-sampling
is easy to perform, less painful, less embarrassing, and
less anxiety provoking than the Pap test [11,12]. Further-
more, HPV self-sampling has been reported to increase
cervical cancer screening compliance for women who
have never or not regularly been screened for cervical
cancer [5,13].
Cervical cancer was the seventh leading cause of can-
cer mortality among Taiwanese women in 2012 [14].
Taiwan’s National Health Insurance has been reimburs-
ing women ≥30 years old for annual Pap tests since 1995
and women ≥36 years old who had not had a Pap test
within ≥6 years for self-collected HPV samples since
2010 [14]. This reimbursement policy led to a gradual
but significant increase in annual participation in Pap
screening from 35.0% in 1997 to 56.2% in 2011 [14].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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have never or not regularly participated in cervical
screening in 2011 [14]. Self-collected HPV sampling may
improve the cervical cancer screening rate for women
who currently do not participate in regular cervical can-
cer screening in Taiwan, as in western countries [3,13].
However, little research has been done on HPV self-
sampling in Taiwan. It is important to identify and target
women who are likely to accept self-collected HPV sam-
pling for cervical screening. Thus, the aim of this study
was to explore determinants of women’s likelihood of
self-sampling for HPV testing.
To explore the likelihood of self-sampling for HPV, we
reviewed the literature on factors impacting uptake of
HPV vaccination, Pap test, and cervical cancer screening
because these factors may also affect uptake of HPV self-
sampling. For example, women’s willingness to collect
their own HPV samples is crucial [15] because it has
been shown to affect their readiness to self-sample for
HPV. In addition, two prerequisites for making an in-
formed decision about HPV vaccination are awareness
of HPV (having heard of HPV) and knowledge of HPV
[16]. The uptake of cervical screening services was influ-
enced by knowledge of cervical cancer [17,18], previous
Pap testing [11], educational level [3,11], and household
income l [19], but was not associated with marital status
[20]. Furthermore, barriers to Pap testing such as the is-
sues of time [20,21], cost [5,18], and clinical site [21]




This cross-sectional study was conducted between June
and October, 2012. A convenience sample was recruited
from women seeking obstetrical and gynecological health
care but not cervical screening at the gynecologic clinics
of a regional hospital in central Taiwan. Women were ex-
cluded if they reported a history of cervical cancer because
these women received different cervical screening recom-
mendations [22]. After the study was approved by the
Cheng Ching Hospital’s Institutional Review Board (ap-
proval # HP120013), a clinical nurse approached women
in the clinic and told them about the study and their
rights. Those who agreed to participate signed informed
consent and were given a small gift (NT$ 100 [approxi-
mately US$3] cash coupon).
Data collection
Data were collected by questionnaire from June to Octo-
ber 2012. Women respondents were first asked if they
had heard of HPV. If a woman responded “yes”, she was
asked three HPV-related questions: her perceived risk
of cervical cancer (high/low), her priority considerationsfor HPV self-sampling (clinical site, time, and cost), and
if she had ever self-sampled for HPV (yes/no). If a
woman had not heard of HPV, she skipped the first
three questions (see “Determinants of the likelihood of
self-sampling for HPV” below). All women, regardless of
having heard of HPV, were then asked about their will-
ingness to self-sample for HPV (willing, unwilling, un-
decided) and extent of HPV knowledge. HPV knowledge
was measured by 21 true/false items drawn from previ-
ous research [23]. Percentages of correct answers for
women who had heard of HPV are shown in (Additional
file 1). Extent of HPV knowledge was categorized as
high, moderate, and low based on the number of correct
answers above the mode score, between the median and
mode scores, or below the median score, respectively.
Scores of ≥15 points were coded as a high level of know-
ledge, those with 13 to 14 points were coded as moder-
ate knowledge, and those with ≤12 points were coded as
low knowledge.
Demographic variables included age range (18–29, 30–
39, 40–49, 50–65 years), education (≤ high school, college
degree, bachelor’s degree, ≥ graduate degree), annual house-
hold income (≤500,000; 510,000-1,000,000; 1,010,000-1,50-
0,000; 1,510,000-2,000,000; ≥2,010,000 NT$), marital status
(single [divorced, separated, widowed] vs. married), and
residential area (city, town, rural). A related clinical variable
was previous Pap testing (yes/no).
Data analysis
All the data were entered and analyzed using SPSS version
14.0 for Windows (SPSS Inc., Chicago, IL). Data were
analyzed by descriptive statistics, the chi-square test, and
multivariate logistic regression. All women were asked
about their willingness to self-sample for HPV and extent
of HPV knowledge because we wanted to determine
whether having heard of HPV was associated with willing-
ness to self-sample and HPV knowledge.
Results
Sample characteristics
The 500 women who completed our questionnaire were
18–65 years old, with the largest proportion 30–39 years
old (n = 216, 43.2%). A majority of the women was
married (n = 372, 74.4%), had at least a college education
(n = 331, 66.2%), had an annual household income
of < NT$1,000,000 (n = 397, 79.4%), and lived in a city
(n= 378, 75.6%). The majority of women had had Pap testing
(n= 331, 66.2%) and had heard of HPV (n= 297, 59.4%). For
details, see Table 1.
Among the 297 women who had heard of HPV, a major-
ity had had Pap testing (n = 206, 69.4%) and perceived that
they had a low risk of cervical cancer (n = 207, 69.7%).
Regarding priority considerations for HPV self-sampling, a
majority (n = 234, 78.8%) was concerned about cost. Two-
Table 1 Sample characteristics
Characteristics n % n %
All women (N = 500) Women who heard of HPV (N = 297)
Age, years Previous Pap testing
≤29 138 27.6 Yes 206 69.4
30-39 216 43.2 No 91 30.6
40-49 106 21.2 Perceived risk of cervical cancer
≥50 40 8.0 High 90 30.3
Education Low 207 69.7
≤High school 169 33.8 Willingness to self-sample for HPV
College 131 26.2 Willing 196 66.0
Baccalaureate degree 177 35.4 Unwilling/undecided 101 34.0
≥Graduate degree 23 4.6 HPV knowledgeb
Annual household income (NT$) High 76 25.6
≤500,000 194 38.8 Moderate 127 42.8
510,000-1,000,000 203 40.6 Low 94 31.6
1,010,000-1,500,000 67 13.4 Priority consideration for HPV self-sampling
1,510,000-2,000,000 22 4.4 Cost 234 78.8
≥2,010,000 14 2.8 Clinical site/time 63 21.2
Marital status












aD refers to divorced, S refers to separated, W refers to widowed.
bHPV knowledge was categorized as high, moderate, and low based on the number of correct answers above the mode score, between median and mode score,
or below the median score, respectively. Scores of ≥15 points were coded as “high” knowledge, those with 13 to 14 points were coded as “moderate” knowledge,
and those with ≤12 points were coded as low knowledge.
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HPV (n = 196, 66%), and the largest proportion had a
moderate level of HPV knowledge (n = 127, 42.8%). For
details, see Table 1. Most of these women also under-
stood that HPV can cause cervical cancer (97.3%), can
cause serious health problems for women (94.9%), can-
not be transmitted by kissing (94.3%), and can be sexu-
ally transmitted (92.9%). However, few of them knew
that using condoms during sexual intercourse is only
partially effective in preventing the spread of HPV
(8.4%), HPV infection cannot be treated (13.8%), and
HPV cannot be transmitted by the exchange of bodily
fluids (blood, semen) (14.1%) (Additional file 1).Determinants of the likelihood of self-sampling for HPV
If a woman had not heard of HPV, her data were not in-
cluded in the analysis of determinants of women’s likeli-
hood to self-sample for HPV because not having heard of
HPV indicates unawareness of HPV [24]. Associations be-
tween demographic/clinical variables and the likelihood of
HPV self-sampling among those who had heard of HPV
were analyzed using χ2 statistics. Significant associations
(p < 0.05) were used as the cutoff for selecting determi-
nants in multivariate logistic regression analysis for the
likelihood of women’s self-sampling for HPV.
Among the 297 women who had heard of HPV, 69
(23%) had self-sampled for HPV (Table 2). Our analysis
Table 2 Characteristics associated with the likelihood of
HPV self-sampling among women who had heard of HPV
Characteristic
Ever self-sampled for HPV among
women who had heard of HPV (N =
297)
Yes No
χ2n = 69 (23%) n = 228 (77%)
n (%) n (%)
Age range, years 7.54
≤ 29 9 (13.0) 60 (87.0)
30-39 33 (25.2) 98 (74.8)
40-49 19 (24.7) 58 (75.3)
≥ 50 8 (40.0) 12 (60.0)
Education 1.54
≤ High school 18 (23.4) 59 (76.6)
College 18 (21.7) 65 (78.3)
Bachelor’s degree 27 (22.5) 93 (77.5)
≥ Graduate degree 6 (35.3) 11 (64.7)
Annual household income (NT$) 7.27
≤ 500,000 16 (16.8) 79 (83.2)
510,000-1,000,000 32 (24.6) 98 (75.4)
1,010,000-1,500,000 10 (24.4) 31 (75.6)
1,510,000-2,000,000 5 (26.3) 14 (73.6)
≥ 2,010,000 6 (50.0) 6 (50.0)
Marital status 0.18
Single (D, S, W)a 17 (21.5) 62 (78.5)
Married 52 (23.9) 166 (76.1)
Residential area 0.14
City 55 (23.6) 178 (76.4)
Town 10 (22.7) 34 (77.3)
Rural 4 (20.0) 16 (80.0)
Previous Pap testing 32.5***
Yes 67 (32.5) 139 (67.5)
No 2 (2.2) 89 (97.8)
Perceived risk of cervical cancer 5.85**
High 29 (32.2) 61 (67.8)
Low 40 (19.3) 167 (80.7)
Willingness to self-sample 6.03*
Willing 54 (27.6) 142 (72.4)
Unwilling/undecided 15 (14.9) 86 (85.1)
HPV knowledgeb 11.2**
High 28 (36.8) 48 (63.2)
Moderate 26 (20.5) 101 (79.5)
Low 15 (16.0) 79 (84.0)
Table 2 Characteristics associated with the likelihood of




Cost 47 (20.1) 187 (79.9) 6.125*
Clinical site/time 22 (34.9) 41 (65.1)
aD refers to divorced, S refers to separated, W refers to widowed.
bHPV knowledge was categorized as high, moderate, and low based on the
number of correct answers above the mode score, between median and
mode score, or below the median score, respectively. Scores of ≥15 points
were coded as a high level of knowledge, those with 13 to 14 points were
coded as moderate knowledge, and those with ≤12 points were coded as
low knowledge.
*p < 0.05, **p < 0.01, ***p < 0.001.
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self-sampling for HPV was significantly associated with
five factors: previous Pap testing, perceived risk of cer-
vical cancer, willingness to self-sample, extent of HPV
knowledge, and priority considerations for HPV self-
sampling. Women who had previous Pap testing and
high perceived risk of cervical cancer were more likely
to self-sample for HPV than women with no previous
Pap testing and low perceived risk of cervical cancer, re-
spectively. Women who were willing to self-sample for
HPV were more likely to self-sample for HPV than those
who were unwilling and undecided. Women with high
HPV knowledge were more likely to self-sample for
HPV than those with low and moderate HPV know-
ledge. Women with a priority consideration of cost were
less likely to self-sample for HPV than those with a pri-
ority consideration of clinical site/time. In addition, bi-
variate analyses revealed that, among women who had
heard of HPV, ever self-sampling for HPV was not sig-
nificantly associated with demographic characteristics.
For details, see Table 2.
The results of multivariate logistic regression analyses
are presented as factors predicting the likelihood of self-
sampling for HPV (Table 3). The results show that the full
model, which considered all five independent variables
together, was statistically significant (χ2 = 72.933, df = 6,
n = 297, p < 0.001). This result implies that the odds of a
woman self-sampling for HPV were related to these five
independent variables, i.e., previous Pap testing, perceived
risk of cervical cancer, willingness to self-sample, extent of
HPV knowledge, and priority considerations for HPV self-
sampling. This model also passed tests of goodness of fit
and of collinearity. Regarding goodness of fit, the final
model passed the Hosmer and Lemeshow test and was
not significant (p = 0.945). Each variable also passed tests
for collinearity, with all tolerance scores >0.95, which
exceeded the suggested criterion of 0.1 [25], and all VIF
(variance inflation factor) scores <2, which is well below
the cutoff value of 10 [26]. This model correctly classified
78.8% of women who had self-sampled for HPV. The
Table 3 Logistic regression analysis of determinants for
likelihood of HPV self-sampling (N = 297)
Determinant β Odds ratio
(95% confidence interval)
Previous Pap testing
Yes 3.09*** 22.00 (5.10, 95.02)
No 1 (ref)a
Perceived risk of cervical cancer
High 0.81* 2.25 (1.17, 4.32)
Low 1 (ref)a
Willingness to self-sample





1.24** 3.47 (1.53, 7.88)
Moderate
(60%-69% correct answers)






Cost −1.30** 0.27 (0.13, 0.59)
Clinical site/time 1 (ref)a
Constant −4.39*** 0.001
aref indicates reference group.
χ2:72.933, df = 6, Hosmer & Lemeshow: p = 0.945, −2log likelihood: 249.056,
Cox & Snell R2: 0.218, Nagelkerke R2: 0.329.
*p < 0.05, **p < 0.01, ***p < 0.001.
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tween 21.8% (Cox and Snell R2) and 32.9% (Nagelkerke R2)
of variance in the likelihood of self-sampling for HPV.
The odds ratios in Table 3 indicate the factor increases
(ratios >1) and decreases (ratios <1) in a woman’s odds
of self-sampling for HPV if all other variables are held
constant. The strongest determinant of the likelihood of
self-sampling for HPV was having had a previous Pap
test. Women who had a previous Pap test had 22 times
the odds of self-sampling for HPV than those who had
not (OR 22.00, 95% CI 5.10-95.02, p < 0.001).
Another strong determinant of women’s likelihood
of self-sampling for HPV was priority considerations for
HPV self-sampling (Table 3). Women whose priority
consideration was cost had significantly lower odds of
self-sampling for HPV than those whose priority was
clinical site/time considerations (OR 0.27, 95% CI 0.13-
0.59, p < 0.01).
Other determinants that significantly contributed to the
model were extent of HPV knowledge, willingness to self-
sample, and perceived risk of cervical cancer (Table 3).
Women with high HPV knowledge had significantly
greater odds of self-sampling for HPV than those with lowHPV knowledge (OR 3.47, 95% CI 1.53-7.88, p < 0.01).
Women who were willing to self-sample for HPV had
significantly greater odds of self-sampling for HPV than
women who were unwilling/undecided (OR 3.09, 95% CI
1.41-6.76, p < 0.01). Women whose perceived risk of cervical
cancer was high had significantly greater odds of self-sampling
for HPV than women who perceived a low risk (OR 2.25,
95% CI 1.17-4.32, p < 0.05).Discussion
This study contributes to knowledge about the factors
related to the likelihood of a clinical sample of Taiwan-
ese women to self-sample for HPV. The majority of our
women respondents (59.4%) had heard of HPV, and
most of these women (97.3%) understood that HPV
causes cervical cancer. However, the remaining 40.6% of
our sample had not heard of HPV and did not under-
stand its link to cervical cancer. Although a majority of
women had heard of HPV and had moderate-to-high
levels of HPV knowledge, they misunderstood important
information about the virus, such as condom use only
partially protects against transmission of HPV and HPV
cannot be transmitted by exchange of bodily fluids
(blood, semen). Our results echo those of a study with
US college students, most of whom had heard of HPV
and had moderate HPV knowledge but did not under-
stand important HPV facts related to cervical cancer
[24]. In addition, women who had heard of HPV were
more likely to be willing to self-sample for HPV than
those who had not heard of HPV. Together, these findings
highlight the importance of disseminating information
about HPV.
Women’s likelihood of self-sampling for HPV was
most strongly predicted by previous Pap testing, consist-
ent with the strongest determinant of intent to undergo
future Pap smear screening being prior screening [18].
This result is not surprising, given that most women
know and accept the Pap smear as an effective method
for cervical screening despite the side effects of discom-
fort and embarrassment [3,6,27]. In this respect, self-
sampling for HPV is a less painful and embarrassing
procedure than the Pap test. Thus, women who have
undergone previous Pap testing are strongly enough mo-
tivated to participate regularly in self-sampling for HPV
to prevent cervical cancer or detect it early. We note the
discrepancy in our findings between the number of
women who had had a Pap test (n = 331) and those who
had heard of HPV (n = 297), suggesting that some
women who had a Pap test had not heard of HPV. This
may have been due to their doctors not explaining that
HPV has been linked to the cytological changes that the
Pap test detects or the women not understanding or re-
membering their doctor’s explanation.
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self-sampling for HPV was cost priority consideration.
Cost is a highly negative predictor of self-sampling for
HPV. This finding is similar to other studies that vaccine’s
cost would impede vaccination [16,28,29].
Three other determinants of women’s likelihood of
self-sampling for HPV were extent of HPV knowledge,
willingness to self-sample for HPV and perceived risk
of cervical cancer. Similar to a previous report that
Turkish women’s acceptance of Kato’s device as an al-
ternative to the Pap smear was related to knowledge of
HPV and cancer [6]. This result, taken with our finding
that even women with moderate-to-high HPV know-
ledge did not understand some important aspects of
HPV knowledge suggest the importance of education
programs to increase the likelihood of self-sampling
for HPV.
Our findings are consistent with previous findings that
willingness to self-sample for HPV was a determinant of
future HPV self-sampling [9]. Willingness to self-sample
for HPV is a logical predictor for likelihood of HPV self-
sampling because without willingness, a health behavior
will not occur [30]. Additionally, our clinical sample’s
likelihood of HPV self-sampling was predicted by a
higher perceived likelihood of getting cervical cancer.
This result is consistent with research on acceptability of
Kato’s device for cervical cancer screening [6] and low
perceived risk of cervical cancer as a major reason for
Malaysian women never having a Pap smear [31].Limitations
The results of our study are subject to some limitations.
First, our results are based on data from a gynecological
clinic sample recruited from central Taiwan, and only 69
respondents had ever self-sampled for HPV. Thus, the
results may not be generalizable to all women in Taiwan.
Second, not having heard of HPV does not mean that a
woman has no opinion of her risk of cervical cancer or
did not self-sample for HPV. Further research should
ask women about their perceived risk of cervical cancer
and whether they have ever self-sampled for HPV, re-
gardless of whether they have heard of HPV. Third, de-
terminants of the likelihood of HPV self-sampling were
examined only among women who had heard of HPV.
More research is needed to find effective methods to
disseminate information about HPV to increase the pro-
portion of women aware of HPV and to improve their
understanding of the link between HPV and cervical
cancer. More accurate and complete knowledge about
HPV may increase cervical screening rates among women
who do not regularly participate in screening by increasing
their willingness to self-sample for HPV as reported for
native women in Canada [13].Conclusions
Taiwanese women’s likelihood of HPV self-sampling was
predicted by having had a previous Pap test, perceiving a
high risk of cervical cancer, willingness to self-sample
for HPV, a high level of HPV knowledge, and a cost pri-
ority consideration. Therefore, outreach efforts to in-
crease the acceptability of self-sampling for HPV should
disseminate information about HPV to increase the rate
of women who have heard of HPV and target women
who not only have had a Pap test, but also perceive
themselves at high risk for cervical cancer, are willing to
self-sample for HPV, and have a high level of HPV
knowledge. Another important concern for HPV self-
sampling is that its cost is covered by health insurance.
These findings can be used by policy makers to plan
appropriate activities and strategies to educate women
about HPV self-sampling for cervical screening, as well
as to target women who are likely to accept HPV self-
sampling, and in turn to increase regular cervical screen-
ing participation in Taiwan.Additional file
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